- Home
- NERV vs WKSP Comparison
NERV vs WKSP Comparison
Compare NERV & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- WKSP
- Stock Information
- Founded
- NERV 2007
- WKSP 2003
- Country
- NERV United States
- WKSP United States
- Employees
- NERV N/A
- WKSP N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- WKSP Auto Parts:O.E.M.
- Sector
- NERV Health Care
- WKSP Consumer Discretionary
- Exchange
- NERV Nasdaq
- WKSP Nasdaq
- Market Cap
- NERV 14.6M
- WKSP 14.6M
- IPO Year
- NERV 2014
- WKSP N/A
- Fundamental
- Price
- NERV $2.83
- WKSP $3.63
- Analyst Decision
- NERV Hold
- WKSP Strong Buy
- Analyst Count
- NERV 1
- WKSP 3
- Target Price
- NERV $5.00
- WKSP $12.83
- AVG Volume (30 Days)
- NERV 639.5K
- WKSP 439.4K
- Earning Date
- NERV 11-04-2025
- WKSP 11-12-2025
- Dividend Yield
- NERV N/A
- WKSP N/A
- EPS Growth
- NERV N/A
- WKSP N/A
- EPS
- NERV 1.48
- WKSP N/A
- Revenue
- NERV N/A
- WKSP $12,395,166.00
- Revenue This Year
- NERV N/A
- WKSP $154.90
- Revenue Next Year
- NERV N/A
- WKSP $80.70
- P/E Ratio
- NERV $1.47
- WKSP N/A
- Revenue Growth
- NERV N/A
- WKSP 232.13
- 52 Week Low
- NERV $1.15
- WKSP $2.44
- 52 Week High
- NERV $3.29
- WKSP $12.00
- Technical
- Relative Strength Index (RSI)
- NERV 70.41
- WKSP 49.68
- Support Level
- NERV $2.06
- WKSP $3.26
- Resistance Level
- NERV $2.15
- WKSP $3.90
- Average True Range (ATR)
- NERV 0.11
- WKSP 0.29
- MACD
- NERV 0.02
- WKSP 0.00
- Stochastic Oscillator
- NERV 70.72
- WKSP 36.95
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.